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Background: We have previously demonstrated in rats with acute myocardial infarctions that human umbilical cord blood mononuclear cells 
(HUCBC), which contain mesenchymal, hematopoietic, and endothelial stem cells, significantly reduce the size of acute myocardial infarctions by as 
much 86%, increase LV ejection fraction by 35% and LV contractility and relaxation by as much as 34-81% compared with saline treated infarcted 
hearts without the requirements for rat immune suppression (Cell Transplantation 2004, 2006, 2007). 
Methods: In order to determine paracrine mechanisms whereby HUCBC can increase vascular endothelial cell and cardiac myocyte survival during 
myocardial injury, we determined by microarray the growth factor and anti-inflammatory cytokines secreted by HUCBC into culture media during 
hypoxia (1% O2, 94% N2, 5% CO2) for 12 hrs (N=10). We then treated human coronary artery endothelial cell cultures and also cardiomyocyte 
cultures with either acellular culture media taken from hypoxic HUCBC cultures (N=6) or normal culture media (N=6) and subjected the endothelial 
cell and myocyte cultures to 24 hours of hypoxia or 24 hrs of normoxia. Thereafter, we determined coronary endothelial cell and cardiac myocyte 
apoptosis by cell morphology, annexin V staining and caspase determinations and cell necrosis by Trypan Blue dye and propidium iodide staining. 
Results: Hypoxic stressed HUCBC significantly increased the secretion of hepatocyte growth factor by more than 375%. Increased the secretion of 
angiogenic factors angiopoietin, angiogenin and vascular endothelial growth factor by more than 100-200%, and increased the secretion of the anti-
inflammatory cytokines IL-4 and IL-10 more than 80%. Acellular HUCBC media reduced apoptosis of coronary artery endothelial cells and cardiac 
myocytes by 36 and 49% (p<0.05). Coronary artery endothelial cell and cardiac myocyte necrosis was decreased by 30 and 39% (p<0.05). 
Conclusion: HUCBC protect ischemic and injured myocardium by secretion of biologically active growth factors and anti-inflammatory cytokines 
that significantly limit hypoxic induced apoptosis and necrosis of vascular endothelial cells and cardiac myocytes.
